Fate Therapeutics fatetherapeutics.com


Public list: BIO 2016 (619) Pharma Startups (4732)

Fate Therapeutics (NASDAQ: FATE) is a biotechnology company developing stem cell modulators (SCMs), biologic or small molecule compounds that guide cell fate, to treat patients with very few therapeutic options. Fate Therapeutics' lead clinical program, ProHema, consists of pharmacologicallyenhanced hematopoietic stem cells (HSCs) designed to improve HSC support during the normal course of a stem cell transplant for the treatment of patients with hematologic malignancies. The Company is also adv...Show all

Fate Therapeutics (NASDAQ: FATE) is a biotechnology company developing stem cell modulators (SCMs), biologic or small molecule compounds that guide cell fate, to treat patients with very few therapeutic options. Fate Therapeutics' lead clinical progr...Show all

Company (IPO / Went public)

Phone: 858-875-1800

Fax:

3535 General Atomics Court
Suite 200
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Fate Therapeutics $116.5M Oct 1, 2013
OncoMed Pharmaceuticals $376.2M Jul 18, 2013
Horizon Therapeutics $63M Jul 10, 2009
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Fate Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Stem cell culture media and methods of enhancing cell survival Mar 13, 2014 Apr 17, 2018 Patent
Wnt compositions and therapeutic uses of such compositions Sep 14, 2012 Jan 23, 2018 Patent
Cell culture platform for single cell sorting and enhanced reprogramming of ipscs Dec 19, 2011 Aug 15, 2017 Patent
Enhanced stem cell composition Nov 29, 2012 Sep 27, 2016 Patent
Wnt compositions and therapeutic uses of such compositions Jan 11, 2012 Aug 02, 2016 Patent
See all 16 patents